reported the mechanism of atypical NLRP3 inflammasome activation in MG during the effector phase of EAE, suggesting that the deficiency in the adaptor molecule ASC of NLRP3 inflammasome in MG may weaken T cell proliferation and neutrophil infiltration. Here, NLRP3 is linked to myasthenia gravis.